CDRH Unveils Postmarket Safety “Action Items”
This article was originally published in The Gray Sheet
Executive Summary
FDA's plan to strengthen postmarket device safety by making better use of postmarket data includes modifying its organizational infrastructure, updating adverse event reporting practices and potentially increasing the use of fines for certain types of industry noncompliance